Who is sponsoring NCT04574479?

NCT04574479 is sponsored by University of Liege.

What drugs are being tested in NCT04574479?

Interventions in NCT04574479: Supra-inguinal fascia iliaca compartment block, Multimodal analgesia and PCA morphine pump.

What condition does NCT04574479 study?

NCT04574479 studies Arthropathy of Hip.

Is NCT04574479 still recruiting?

NCT04574479 is currently completed. Last updated 17 May 2022.

Last reviewed 2022-05-17 · How we verify

NCT04574479

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Management in Total Hip Arthroplasty by Posterior Approach

Completed Phase 4 Last updated 17 May 2022

What this trial tests

Phase 4 trial testing Supra-inguinal fascia iliaca compartment block in Arthropathy of Hip in 86 participants. Completed in 2 September 2021.

Timeline

16 December 2020

Primary endpoint
1 September 2021

2 September 2021

Quick facts

Lead sponsor	University of Liege
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	86
Start date	16 December 2020
Primary completion	1 September 2021
Estimated completion	2 September 2021
Sites	1 location across Belgium

Drugs / interventions tested

Supra-inguinal fascia iliaca compartment block
Multimodal analgesia and PCA morphine pump — full drug profile →

Conditions studied

Arthropathy of Hip — all drugs for Arthropathy of Hip →

Sponsor

University of Liege

Who can join

Adults 18 to 85, any sex, with Arthropathy of Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Find the impact of supra-inguinal fascia iliaca compartment block on postoperative pain management after total hip arthroplasty by posterior surgical approach

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of suprainguinal fascia iliaca compartment block on postoperative opioid consumption and functional recovery in posterolateral-approached total hip arthroplasty: a single-blind randomized controlled trial.
Carella M, Beck F, Piette N, Denys S, et al · · 2022 · cited 22× · PMID 35705263 · DOI 10.1136/rapm-2021-103427

Verify or expand the search:

Other trials of Supra-inguinal fascia iliaca compartment block

Trials testing the same drug.

NCT04426045 — Pericapsular Nerve Group (PENG) Block Versus Supra-inguinal Fascia Iliaca Compartment Block for Pain Management After To · NA · completed

Other recruiting trials for Arthropathy of Hip

Currently open trials in the same condition.

NCT07327372 — PENG Block With Dexmedetomidine in Older Adults · NA · recruiting
NCT06832995 — Incidence and Risk Factors for Post-Anesthetic Morphine Titration in Recovery Room After Hip and Knee Arthroplasties · active not recruiting
NCT05649007 — Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery · recruiting
NCT05647629 — Observational Study of the Development of Low Back Pain After Total Hip Arthroplasty. · recruiting

Other University of Liege trials

Trials by the same sponsor.

NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04574479 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Liege
Last refreshed: 17 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04574479.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing